Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_assertion description "[A total of 471 treatment-naive patients with histologically proven chronic hepatitis C virus (HCV) infection (106 with cirrhosis; 185 with HCV genotype 1 [HCV-1], 157 with HCV genotype 2 [HCV-2], 92 with HCV genotype 3 [HCV-3] and 37 with HCV genotype 4 [HCV-4]) were consecutively treated with PEG-IFN-alpha2b 1.5 microg weekly and weight-based RBV.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_assertion evidence source_evidence_literature NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_assertion SIO_000772 19578243 NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_assertion wasDerivedFrom befree-2016 NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_assertion wasGeneratedBy ECO_0000203 NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.
- befree-2016 importedOn "2016-02-19" NP749282.RA7zRGlTOScDOyfzmnyVmkDo72u0m9-uqjOpet9gBpTkw130_provenance.